More than half of all American adults, almost 137 million people, could be candidates for the blockbuster GLP-1 drug ...

Ozempic, Mounjaro and other weight loss drugs can have nasty side effects, and reducing the volume of food you eat will also ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

Danish pharmaceutical company Novo Nordisk announced last weekend that Wegovy, the weight-loss version of the company's ...

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

The semaglutide family of drugs ... “Most people come to me for weight loss, and I’ve seen that if they don’t take the standard dose, then they don’t lose weight.” Where she does see micro dosing work ...

More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...